Cargando…

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu(7) Receptor Modulation Activity and Antipsychotic-Like Properties

Following the glutamatergic theory of schizophrenia and based on our previous study regarding the antipsychotic-like activity of mGlu(7) NAMs, we synthesized a new compound library containing 103 members, which were examined for NAM mGlu(7) activity in the T-REx 293 cell line expressing a recombinan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaczorowska, Katarzyna, Stankiewicz, Anna, Bugno, Ryszard, Paluchowska, Maria H., Burnat, Grzegorz, Brański, Piotr, Cieślik, Paulina, Wierońska, Joanna M., Milik, Mariusz, Nowak, Mateusz, Przybyłowicz, Agnieszka, Kozioł, Aneta, Hogendorf, Agata, Hogendorf, Adam S., Kalinowska-Tłuścik, Justyna, Duszyńska, Beata, Pilc, Andrzej, Bojarski, Andrzej J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916658/ https://www.ncbi.nlm.nih.gov/pubmed/36768302 http://dx.doi.org/10.3390/ijms24031981

Ejemplares similares

New 1,2,4-oxadiazole derivatives with positive mGlu(4) receptor modulation activity and antipsychotic-like properties
por: Stankiewicz, Anna, et al.
Publicado: (2021)

Negative Allosteric Modulators of mGlu(7) Receptor as Putative Antipsychotic Drugs
por: Cieślik, Paulina, et al.
Publicado: (2018)

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
por: Pałucha-Poniewiera, Agnieszka, et al.
Publicado: (2010)

The functional cooperation of 5-HT(1A) and mGlu4R in HEK-293 cell line
por: Burnat, Grzegorz, et al.
Publicado: (2020)

N-Skatyltryptamines—Dual 5-HT(6)R/D(2)R Ligands with Antipsychotic and Procognitive Potential
por: Hogendorf, Agata, et al.
Publicado: (2021)

Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
por: Wierońska, Joanna M., et al.
Publicado: (2011)

Mutual activation of glutamatergic mGlu(4) and muscarinic M(4) receptors reverses schizophrenia-related changes in rodents
por: Cieślik, Paulina, et al.
Publicado: (2018)

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
por: Podkowa, Karolina, et al.
Publicado: (2016)

Low-basicity 5-HT(7) Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol
por: Hogendorf, Adam S., et al.
Publicado: (2017)

The effect of the intramolecular C–H⋯O interactions on the conformational preferences of bis-arylsulfones – 5-HT(6) receptor antagonists and beyond
por: Kalinowska-Tłuścik, Justyna, et al.
Publicado: (2018)

Activation of Metabotropic Glutamate Receptor (mGlu(2)) and Muscarinic Receptors (M(1), M(4), and M(5)), Alone or in Combination, and Its Impact on the Acquisition and Retention of Learning in the Morris Water Maze, NMDA Expression and cGMP Synthesis
por: Wierońska, Joanna M., et al.
Publicado: (2023)

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT(1A) signalling
por: Wierońska, Joanna M., et al.
Publicado: (2013)

Involvement of GABA(B) Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu(4) Receptor, LSP4-2022
por: Woźniak, Monika, et al.
Publicado: (2016)

Structural insights into dimerization and activation of the mGlu2–mGlu3 and mGlu2–mGlu4 heterodimers
por: Wang, Xinwei, et al.
Publicado: (2023)

Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies
por: Chruścicka-Smaga, Barbara, et al.
Publicado: (2023)

mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists
por: Zammataro, Magda, et al.
Publicado: (2011)

Allosteric Modulators for mGlu Receptors
por: Gasparini, F, et al.
Publicado: (2007)

Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies
por: Cieślik, Paulina, et al.
Publicado: (2021)

Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice
por: Lane, Tracy A, et al.
Publicado: (2013)

Emotional Impairment and Persistent Upregulation of mGlu(5) Receptor following Morphine Abstinence: Implications of an mGlu(5)-MOPr Interaction
por: Zanos, Panos, et al.
Publicado: (2016)

mGlu1 Receptors Monopolize the Synaptic Control of Cerebellar Purkinje Cells by Epigenetically Down-Regulating mGlu5 Receptors
por: Notartomaso, Serena, et al.
Publicado: (2018)

mGlu5 Receptor Functional Interactions and Addiction
por: Brown, Robyn M., et al.
Publicado: (2012)

mGlu(5) Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu(5)-Endocannabinoid Signaling
por: Xiang, Zixiu, et al.
Publicado: (2019)

Neurobiological Insights from mGlu Receptor Allosteric Modulation
por: O’Brien, Daniel E, et al.
Publicado: (2015)

Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
por: Lans, Isaias, et al.
Publicado: (2020)

Regulation and functional consequences of mGlu(4) RNA editing
por: Hofmann, Christopher S., et al.
Publicado: (2021)

Differential activity of mGlu(7) allosteric modulators provides evidence for mGlu(7/8) heterodimers at hippocampal Schaffer collateral-CA1 synapses
por: Lin, Xin, et al.
Publicado: (2022)

Function of mGlu1 receptors in the modulation of nociceptive processing in the thalamus()
por: Salt, T.E., et al.
Publicado: (2014)

Structural insights into the activation initiation of full-length mGlu1
por: Zhang, Jinyi, et al.
Publicado: (2020)

mGlu2 mechanism-based interventions to treat alcohol relapse
por: Vengeliene, Valentina, et al.
Publicado: (2022)

The role of thalamic group II mGlu receptors in health and disease
por: Copeland, Caroline S., et al.
Publicado: (2022)

Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light
por: Pritchett, David, et al.
Publicado: (2015)

A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding
por: García-Bea, Aintzane, et al.
Publicado: (2017)

Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism
por: Rafało-Ulińska, Anna, et al.
Publicado: (2022)

Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms
por: Cieślik, Paulina, et al.
Publicado: (2021)

Activation of mGlu3 Receptors Stimulates the Production of GDNF in Striatal Neurons
por: Battaglia, Giuseppe, et al.
Publicado: (2009)

Role of the G Protein-Coupled Receptor, mGlu(1), in Melanoma Development
por: Wangari-Talbot, Janet, et al.
Publicado: (2010)

Preclinical and translational studies of fenobam, an mGlu5 NAM, for the treatment of pain
por: Gereau IV, Robert W, et al.
Publicado: (2014)

Phasic and Tonic mGlu7 Receptor Activity Modulates the Thalamocortical Network
por: Tassin, Valériane, et al.
Publicado: (2016)

Place field stability requires the metabotropic glutamate receptor, mGlu5
por: Zhang, Sijie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nmmg8ui58igeh0jltkirfq1pqu